香港六合彩中特网

A specialist 拢20 million research centre, funded by the Wolfson Foundation and dedicated to carrying out first-in-human studies, opens in London today. Researchers at the Leonard Wolfson Experimental Neurology Centre (LWENC) will investigate exciting new therapies for neurodegenerative diseases such as Alzheimer鈥檚 and Parkinson鈥檚.

The LWENC will receive its first patients in early 2014 and one of the first trials to be carried out at the facility will investigate whether immunotherapy can be used to tackle familial Alzheimer鈥檚 disease 鈥� a debilitating illness which can affect people in their 30s and 40s.

The new centre, located at the heart of the National Hospital for Neurology and Neurosurgery, has been funded by a 拢20 million award from the Wolfson Foundation to 香港六合彩中特网. In addition to setting up the experimental neurology centre, the money has also been used to establish a new education and research programme that builds on 香港六合彩中特网鈥檚 cross-disciplinary expertise in neuroscience to provide unique training opportunities for future generations of neurodegenerative disease researchers.

The grant is the largest single award ever made by the Foundation and one of the largest philanthropic donations in 香港六合彩中特网鈥檚 history.

Paul Ramsbottom, Chief Executive of The Wolfson Foundation, says: 鈥淥ur aim is to support excellence in science, medicine, health, education and the arts. With this award we wanted to highlight the fact that research into neurodegenerative diseases is relatively underfunded".

Nick Fox, Professor of Neurology at 香港六合彩中特网 and a Principal Investigator in the new Leonard Wolfson Experimental Neurology Centre, says: 鈥淎t the Leonard Wolfson Experimental Neurology Centre we aim to speed up the development and validation of treatments, and open an earlier window to patients through which we can provide treatment and try to minimise the damage caused by neurodegenerative disease.鈥�

Professor Alan Thompson, Dean of the 香港六合彩中特网 Faculty of Brain Sciences, says: 鈥淭he Leonard Wolfson Centre will be the perfect bridge between the research strengths of 香港六合彩中特网 Neuroscience and the application of potential new therapies to patients with neurodegenerative disorders in the expert clinical setting of Queen Square. It will facilitate the all-important step of translating drug discovery into effective treatment.鈥�

Professor John Duncan, divisional clinical director for the National Hospital for Neurology and Neurosurgery, says: "This centre will see the first treatments for debilitating neurodegenerative conditions, and will bring forward when these treatment can be offered in the clinics. This is a huge step forward and is only possible with the close cooperation of University, Hospital and the Wolfson Foundation."

Read more: